1 (Image 01)
Chemical structure diagrams of the active ingredients Norethindrone Acetate and Ethinyl Estradiol, as shown in the product Larin 1.5/30.*
Larin 1.5/30 Kit
Product Images NDC 16714-407
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Larin 1.5/30 (NDC 16714-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
2 (Image 02)
A table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method' listing various contraceptive methods with corresponding percentage rates of unintended pregnancies. Methods include oral contraceptives, diaphragm, spermicides, vaginal sponge, implant, injection, IUD, condoms, cervical cap, periodic abstinence, withdrawal, and sterilization, with lowest expected and typical failure rates provided where available.*
3 (Image 03)
Text warning about increased cardiovascular risks related to cigarette smoking and oral contraceptive use, noting higher risks with age and heavy smoking, especially for women over 35 years. Advises women using oral contraceptives to avoid smoking.*
4 (Image 04)
A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use' showing mortality rates across four age groups (15-24, 25-34, 35-44, 45+) categorized by ever-users and controls, further divided into smokers and non-smokers. Mortality rates increase notably with age, particularly in smokers who are ever-users of oral contraceptives.*
5 (Image 05)
A data table titled 'Annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women by fertility control method according to age.' It lists death rates for various fertility control methods, including no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, across different female age groups ranging from 15-19 to 40-44 years.*
6 (Image 06)
A warning text panel alerting that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 years and with heavy smoking (15 or more cigarettes per day). It advises women using oral contraceptives not to smoke.*
7 (Image 07)
Instructional diagram showing how to use the Larin 1.5/30 kit, with guidance on placing the day label strip according to the start day of the menstrual period and indicating the direction to take pills from left to right each week. The image includes a hand adjusting the day label strip above a blister pack of pills labeled with days of the week.*
8 (Image 08)
Text panel warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially with age and heavy smoking (15 or more cigarettes per day), and is particularly marked in women over 35 years old. Women using oral contraceptives are strongly advised not to smoke.*
9 (Image 09)
A data table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age groups. Methods include no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates presented for age ranges 15-19 through 40-44.*
10 (Image 10)
An instructional diagram showing how to use the Larin 1.5/30 kit (Norethindrone Acetate/Ethinyl Estradiol). It demonstrates placing the day label strip starting with the first day of the user's period for day-1 starters, and directs taking pills left to right each week. The diagram includes labeled days of the week above pill locations in a weekly layout.*
11 (Image 11)
12 (Image 12)
Packaging label for Larin 1.5/30 kit, containing Norethindrone Acetate and Ethinyl Estradiol tablets by Northstar Rx LLC. The label features the product name with dosage, active ingredients, a flower image, NDC 16714-407-03, and dispensing information for 3 blister cards of 21 tablets each. It includes storage and usage instructions, barcodes, and manufacturer details.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
